DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis
Open Access
- 7 August 2017
- journal article
- research article
- Published by Elsevier BV in Kidney International Reports
- Vol. 3 (1), 56-64
- https://doi.org/10.1016/j.ekir.2017.07.017
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CIIJournal of the American Society of Nephrology, 2016
- Shotgun‐proteomics‐based clinical testing for diagnosis and classification of amyloidosisJournal of Mass Spectrometry, 2013
- Fibrillary Glomerulonephritis and Immunotactoid GlomerulopathyJournal of the American Society of Nephrology, 2008
- Actual Practices in Nephropathology: A Survey and Comparison With Best PracticesAdvances in Anatomic Pathology, 2007
- The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperonesCellular and Molecular Life Sciences, 2006
- Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic featuresKidney International, 2003
- Morphologic and Clinical Features of Fibrillary Glomerulonephritis Versus Immunotactoid GlomerulopathyAmerican Journal of Kidney Diseases, 1993
- Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.1992
- Immunohistochemical Distinction Between Amyloidosis and Fibrillar GlomerulopathyAmerican Journal of Clinical Pathology, 1992
- Fibrillary renal deposits and nephritis.1983